FindTrial
Sign In

MK-0431/ONO-5435 Phase III Clinical Study - Metformin add-on Study for Patients with Type 2 Diabetes Mellitus -

MK-0431/ONO-5435 Phase III Clinical Study - Metformin add-on Study for Patients with Type 2 Diabetes Mellitus -

Status
Unknown
Phases
Phase 3
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080220287
Enrollment
Unknown
Registered
2006-08-07
Start date
2006-08-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

investigational material(s) Generic name etc : MK-0431/ONO-5435 INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational mat

Sponsors

ONO PHARMACEUTICAL CO.,LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The target population is the outpatients >=20 and <75 years of age with type 2 diabetes mellitus (male and female) who have inadequate glycemic control on diet/exercise therapy and metformin as monotherapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy, Safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026